| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Gyre Therapeutics, Inc. (GYRE) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 21 sells. GYRE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.57M | $15.96M | - | |
| 10% | 2.14M | $13.33M | - | |
| CFO | 95.1K | $591.3K | - | |
| Dir | 52.0K | $323.4K | - | |
| CFO | 50.0K | $311.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2025 | Ma Songjiang84 | President | Sell | 4,000 | $11.59 | $46,360.00 | - | -11.8% | -31.9% | |
| Feb 11, 2025 | Ma Songjiang84 | President | Sell | 3,878 | $11.72 | $45,434.56 | - | -6.4% | -32.2% | |
| Feb 7, 2025 | Ma Songjiang84 | President | Sell | 4,000 | $12.51 | $50,020.00 | - | -21.7% | -34.9% | |
| Feb 5, 2025 | Ma Songjiang84 | President | Sell | 4,000 | $12.01 | $48,029.00 | - | -32.1% | -41.4% | |
| Feb 3, 2025 | Ma Songjiang84 | President | Sell | 4,000 | $11.49 | $45,960.00 | - | -23.9% | -31.5% | |
| Jan 30, 2025 | Ma Songjiang84 | President | Sell | 4,000 | $11.40 | $45,600.00 | - | -15.1% | -29.7% | |
| Jan 28, 2025 | Ma Songjiang84 | President | Sell | 4,000 | $11.35 | $45,380.00 | - | -20.6% | -31.6% | |
| Jan 24, 2025 | Ma Songjiang84 | President | Sell | 4,000 | $10.69 | $42,760.00 | - | -18.5% | -29.8% | |
| Jan 22, 2025 | Ma Songjiang84 | President | Sell | 4,000 | $10.74 | $42,960.00 | - | -19.3% | -24.8% | |
| Jan 17, 2025 | Ma Songjiang84 | President | Sell | 4,000 | $10.72 | $42,860.00 | - | -18.9% | -29.9% |